Instruction for use: Salgim tablets 0,004 g

Active substance Salbutamol

ATX Code R03CC02 Salbutamol

Pharmacotherapeutic group:

Beta-adrenergic agonist

The nosological classification (ICD-10)

J44 Other chronic obstructive pulmonary disease

Allergic bronchitis, Bronchitis asthma, Asthmatic bronchitis, wheeze bronchitis, Bronchitis is an obstructive, bronchi disease, Shortness of sputum in acute and chronic respiratory diseases, Cough in inflammatory diseases of the lung and bronchus, Reversible airflow obstruction, Reversible obstructive airway disease, Obstructive bronchitis disease, Obstructive lung disease, Obstructive bronchitis, Spastic bronchitis, Chronic lung disease, Chronic nonspecific lung diseases, Chronic obstructive pulmonary disease, Chronic obstructive bronchitis, Chronic obstructive airway disease, Chronic obstructive pulmonary disease, Restrictive lung pathology

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

Structure and Composition

The powder for inhalation dose 1 dose

250 mcg salbutamol hemisuccinate

inhalers "tsiklohalera" 200 doses; in a cardboard box 1 pc.

Salgim® solution for inhalation

A solution for inhalation

salbutamol hemisuccinate of 1 mg / ml

in vials of 2.5; 5; 10 ml or 50; in a cardboard box of 10 vials.

Salgim® pills 0.004 g

Tablets 1 tab.

salbutamol hemisuccinate 0.004 g

Patients plastic 50 pcs .; In the paper cartons 1 bottle.

pharmachologic effect

bronchodilatory.

Selectively stimulates beta2-adrenergic receptors. It relaxes the smooth muscles of the bronchi.

Indications

Bronchial asthma (mild asthma), reversible airflow obstruction, including chronic obstructive bronchitis (

Contraindications

Hypersensitivity, pregnancy (I and II trimesters).

Pregnancy and breast-feeding

It contraindicated in I and II trimesters of pregnancy. Careful - lactation.

Side effects

From the nervous system and sensory organs: tremor (especially hands), headache, anxiety, nervous tension.

Cardio-vascular system and blood (blood, hemostasis): low blood pressure, increased heart rate.

Other: paradoxical bronchospasm, hypokalemia.

Interaction

Compatible with other asthma medications (corticosteroids, Membrane stabilizers, antihistamines, expectorants, mucolytics, anticholinergics, xanthine).

Dosing and Administration

Salgim®

Inhalation using individual portable inhaler "tsiklohalera» 250-500 g (1-2 inhalation dose) at the reception. In bronchial asthma, mild - 1-2 dose 1-4 times a day and an average disease severity - at the same dosage in combination with other antiasthmatic drugs (up to 4 times a day). To prevent asthma physical effort - for 20-30 minutes before loading dose of 1-2 at the reception.

Salgim® solution for inhalation

Inhalation using individual portable inhaler "nebulizer". When using the inhaler through "Nebulizer" initial dose of 2.5 mg every 4-6 hours (if necessary - every 30-60 minutes) for the first 24-48 hours prior to treatment or stabilization of clinical picture (effect usually appears after 10-15 minutes ).

Salgim® pills 0.004 g

Inside, and 0.004 g of 2-3 times per day.

Overdose

Symptoms: weakness, muscle tremors, tachycardia, drop in blood pressure.

Treatment: symptomatic therapy, the introduction of cardioselective beta-blockers.

Precautionary measures

Not recommended simultaneous with beta-blockers.

Caution must be exercised in patients with hyperthyroidism, diabetes, arrhythmia, myocarditis, with heart disease, hypertension, congestive heart failure, glaucoma.

the solution should not be mixed with other drugs.

Storage conditions

In a dry, dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

The shelf life

Tablets 0.004 g - 5 years.

solution for inhalation of 1 mg / ml - 2 years.

powder for inhalation dose of 250 mcg / dose - 3 years.

Do not use beyond the expiration date printed on the package.